US stocks SONN pre-market rise over 270%, announced the establishment of "HYPE version of micro strategy" holding 12.6 million HYPE and 300 million cash.

BlockBeats news, on July 14, the stock price of the US-listed company Sonnet BioTherapeutics Holdings, Inc. (SONN) rose 273.11% in pre-market trading, with a pre-market trading price of $19.29, an increase of $14.05 compared to the previous trading price. BlockBeats previously reported that the US-listed company Sonnet will merge to form Hyperliquid Strategies and initiate a treasury strategy, holding 12.6 million HYPE and $300 million in cash.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • 2
  • Share
Comment
0/400
Zegnavip
· 5h ago
Just go for it💪
View OriginalReply0
Zegnavip
· 5h ago
Just go for it💪
View OriginalReply0
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate app
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)